management primary pulmonary hypertension Primary pulmonary hypertension clinical syndrome pulmonary hypertension absence sufficient underlying cardiac parenchymal pulmonary systemic disease population patients primary pulmonary hypertension heterogeneous etiologic mechanisms unknown therapy consequences pulmonary vascular process Oxygen supplementation use digoxin diuretics symptomatic heart failure anticoagulation role primary pulmonary hypertension vasodilator therapy main area investigation vasodilator responsiveness favorable vasodilator effect long-term effectiveness controversial New approaches use high-dose calcium channel-blocking agents continuous intravenous infusion prostacyclin investigational agent medical therapies heart-lung lung transplantation option patients 